Moderate Pain - Pipeline Review, H2 2013:Industry Analysis Report @ http://www.researchmoz.us/moderate-pain-pipeline-review-h2-2013-report.html

1. Moderate Pain - Pipeline Review, H2 2013
Global Markets Directs, 'Moderate Pain Pipeline Review, H2 2013', provides an overview of the indications
therapeutic pipeline. This report provides information on the therapeutic development for Moderate Pain,
complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key
players involved in the therapeutic development for Moderate Pain. Moderate Pain Pipeline Review, Half
Year is built using data and information sourced from Global Markets Directs proprietary databases,
Company/University websites, SEC filings, investor presentations and featured press releases from
company/university sites and industry-specific third party sources, put together by Global Markets Directs
team.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of
data for the indicated disease.
Scope
A snapshot of the global therapeutic scenario for Moderate Pain. A review of the Moderate Pain products
under development by companies and universities/research institutes based on information derived from
company and industry-specific sources. Coverage of products based on various stages of development ranging
from discovery till registration stages. A feature on pipeline projects on the basis of monotherapy and
combined therapeutics. Coverage of the Moderate Pain pipeline on the basis of route of administration and
molecule type. Key discontinued pipeline projects. Latest news and deals relating to the products.
Reasons to buy
Identify and understand important and diverse types of therapeutics under development for Moderate Pain.
Identify emerging players with potentially strong product portfolio and design effective counter-strategies to
gain competitive advantage. Plan mergers and acquisitions effectively by identifying players of the most
promising pipeline. Devise corrective measures for pipeline projects by understanding Moderate Pain pipeline
depth and focus of Indication therapeutics. Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects to enhance and expand business potential and
scope. Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that
drove them from pipeline.
table Of Contents
table Of Contents 2
list Of Tables 4
list Of Figures 5
introduction 6
global Markets Direct Report Coverage 6
moderate Pain Overview 7
therapeutics Development 8
an Overview Of Pipeline Products For Moderate Pain 8
moderate Pain Therapeutics Under Development By Companies 10
Moderate Pain - Pipeline Review, H2 2013

2. late Stage Products 12
comparative Analysis 12
mid Clinical Stage Products 13
comparative Analysis 13
early Clinical Stage Products 14
comparative Analysis 14
pre-clinical Stage Products 15
comparative Analysis 15
moderate Pain Therapeutics - Products Under Development By Companies 16
companies Involved In Moderate Pain Therapeutics Development 17
nektar Therapeutics 17
esteve Group 18
pain Therapeutics, Inc. 19
pfizer Inc. 20
menarini Group 21
acura Pharmaceuticals, Inc. 22
elite Pharmaceuticals, Inc. 23
charleston Laboratories, Inc. 24
trevena, Inc. 25
qrxpharma Limited 26
kempharm, Inc. 27
theraquest Biosciences, Llc 28
moderate Pain - Therapeutics Assessment 29
assessment By Monotherapy Products 29
assessment By Combination Products 30
assessment By Route Of Administration 31
assessment By Molecule Type 33
drug Profiles 35
pti-202 - Drug Profile 35
product Description 35
mechanism Of Action 35
r&d Progress 35
(oxycodone + Naltrexone) - Drug Profile 36
product Description 36
mechanism Of Action 36
r&d Progress 36
oxycodone Er - Drug Profile 38
product Description 38
mechanism Of Action 38
r&d Progress 38
pti-721 - Drug Profile 40
product Description 40
mechanism Of Action 40
Moderate Pain - Pipeline Review, H2 2013

3. r&d Progress 40
(morphine + Oxycodone) - Drug Profile 41
product Description 41
mechanism Of Action 41
r&d Progress 41
nktr-194 - Drug Profile 43
product Description 43
mechanism Of Action 43
r&d Progress 43
levorphanol Tartrate Er - Drug Profile 44
product Description 44
mechanism Of Action 44
r&d Progress 44
buprenorphine Hydrochloride Er - Drug Profile 45
product Description 45
mechanism Of Action 45
r&d Progress 45
(dexketoprofen Trometamol + Tramadol Hydrochloride) - Drug Profile 46
product Description 46
mechanism Of Action 46
r&d Progress 46
hydromorphone Ir - Drug Profile 47
product Description 47
mechanism Of Action 47
r&d Progress 47
e-58425 - Drug Profile 48
product Description 48
mechanism Of Action 48
r&d Progress 48
hs-731 - Drug Profile 49
product Description 49
mechanism Of Action 49
r&d Progress 49
(promethazine + Hydrocodone + Acetaminophen) - Drug Profile 50
product Description 50
mechanism Of Action 50
r&d Progress 50
(oxycodone Hydrochloride + Naltrexone Hydrochloride) Extended Release - Drug Profile 51
product Description 51
mechanism Of Action 51
r&d Progress 51
trv-734 - Drug Profile 53
product Description 53
Moderate Pain - Pipeline Review, H2 2013

4. mechanism Of Action 53
r&d Progress 53
moderate Pain Therapeutics - Drug Profile Updates 54
moderate Pain Therapeutics - Discontinued Products 58
moderate Pain Therapeutics - Dormant Products 59
moderate Pain - Product Development Milestones 60
featured News & Press Releases 60
sep 10, 2013: Relmada Therapeutics Announces Positive Results Of Levocap Er Pivotal Pharmacokinetic
Study 60
jun 26, 2013: Qrxpharma Updates Moxduo Nda Review 60
may 17, 2012: Janssen Presents Phase Iii Study Results Of Nucynta Er Extended-release Tablets At 31st
Annual Scientific Meeting Of American Pain Society 61
appendix 63
methodology 63
coverage 63
secondary Research 63
primary Research 63
expert Panel Validation 63
contact Us 64
disclaimer 64
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research
reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our
huge collection of market research reports. We provide our services to all sizes of organizations and across all
industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as
publishers and will assist you in making an informed decision by giving you unbiased and deep insights on
which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Moderate Pain - Pipeline Review, H2 2013